Advertisement

Immunogenetics

, Volume 41, Issue 6, pp 388–388 | Cite as

Identification of a novel HLA-A2 subtype, HLA-A*0216

  • Dan Barouch
  • Peter Krausa
  • Julia Bodmer
  • Michael J. Browning
  • Andrew J. McMichael
Sequence Register

References

  1. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506–518, 1987Google Scholar
  2. Bodmer, J. G., Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Dupont, B., Erlich, H. A., Mach, B., Mayr, W. R., Parham, P., Sasazuki, T., Schrueder, G. M. T., Strominger, J. L., Svejgaard, A., and Terasaki, P. I. Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44: 1–18, 1994Google Scholar
  3. Fernandez-Vina, M. A., Falco, M., Sun, Y., and Stastny, P. DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of-A28. Hum Immunol 33: 163–173, 1992Google Scholar
  4. Guttridge, M. G., Marsh, S. G. E., and Klouda, P. T. A new HLA-A2 variant (HLA-A2-SLU) identified by one-dimensional isoelectric focusing. Tissue Antigens 39: 32–34, 1992Google Scholar
  5. Madden, D. R., Gorga, J. C., Strominger, J. L., and Wiley, D. C. The three-dimensional structure of HLA-B27 at 2.1A resolution suggests a general mechanism for tight binding to MHC. Cell 70: 1035–1048, 1992Google Scholar
  6. Parham, P., Lawlor, D. A., Salter, R. D., Lomen, C. E., Bjorkman, P. J., and Ennis, P. D. HLA-A,B,C: patterns of polymorphism in peptide-binding proteins. In B. Dupont (ed.): Immunobiology of HLA, Vol II, pp. 10–32, Springer, New York, 1989Google Scholar
  7. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467, 1977Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Dan Barouch
    • 1
  • Peter Krausa
    • 2
  • Julia Bodmer
    • 2
  • Michael J. Browning
    • 1
  • Andrew J. McMichael
    • 1
  1. 1.Molecular Immunology Group, Institute of Molecular MedicineJohn Radlciffe HospitalHeadingtonUK
  2. 2.Imperial Cancer Research Fund, Institute of Molecular MedicineJohn Radcliffe HospitalHeadingtonUK

Personalised recommendations